Development of an ELISA-LC-MS hybrid assay for quantification of biotherapeutics.

Background: Magnetic bead immunocapture-LC-MS has been widely used for bioanalysis of biotherapeutic proteins. However, magnetic beads are difficult to be fully automated and more costly than ELISA plates.

Aim: Develop an ELISA-LC-MS hybrid assay as an alternate platform.